Detalhe da pesquisa
1.
Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.
Harm Reduct J
; 20(1): 16, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36782321
2.
Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature.
AIDS Behav
; 21(5): 1325-1335, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27900502
3.
Integrating pre-exposure prophylaxis of HIV infection into family planning services: a scoping review.
BMJ Sex Reprod Health
; 49(3): 210-218, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36581443
4.
Shaping and coordinating the implementation science agenda for injectable cabotegravir for PrEP: the role of the Biomedical Prevention Implementation Collaborative (BioPIC).
J Int AIDS Soc
; 26 Suppl 2: e26094, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439050
5.
Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition.
J Int AIDS Soc
; 26 Suppl 2: e26107, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439057
6.
Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition.
AIDS
; 37(6): 957-966, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36723489
7.
Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job?
Lancet HIV
; 9(5): e363-e366, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358418
8.
A Landscape Analysis of Offering HIV Testing Services Within Family Planning Service Delivery.
Front Reprod Health
; 3: 657728, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-36304029
9.
Going global: the adoption of the World Health Organization's enabling recommendation on oral pre-exposure prophylaxis for HIV.
Sex Health
; 15(6): 489-500, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30496718
10.
Long-acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice.
J Int AIDS Soc
; 25(7): e25963, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35903882
11.
HIV PrEP and viral hepatitis: a unique opportunity for integration.
Lancet HIV
; 9(11): e745, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332650
12.
Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis.
AIDS
; 36(13): 1897-1898, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172874
13.
HIV prevalence among injection drug users in rural Guangxi China.
Addiction
; 101(10): 1493-8, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16968351
14.
Beyond the 90-90-90: refocusing HIV prevention as part of the global HIV response.
J Int AIDS Soc
; 19(1): 21348, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27989271
15.
Effectiveness and safety of oral HIV preexposure prophylaxis for all populations.
AIDS
; 30(12): 1973-83, 2016 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27149090
16.
WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs.
Int J Drug Policy
; 25(3): 363-71, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24561223
17.
HIV incidence, retention, and changes of high-risk behaviors among rural injection drug users in Guangxi, China.
Subst Abus
; 27(4): 53-61, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17347126
18.
Guidelines on long-acting injectable cabotegravir for HIV prevention: web annex C: systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis, including long-acting injectable cabotegravir, to prevent HIV infection
Geneva; World Health Organization; 2022.
em Inglês
| WHOLIS | ID: who-360827
19.
Guidelines on long-acting injectable cabotegravir for HIV prevention: web annex B: systematic review, meta-analysis and GRADE evidence profile on safety, efficacy, and effectiveness of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) to reduce the risk of HIV acquisition
Geneva; World Health Organization; 2022.
em Inglês
| WHOLIS | ID: who-360826